CEO Jack Harry Kaye Reports 42% Beneficial Ownership in Davion Healthcare PLC

On April 17, 2026, Jack Harry Kaye, the Chief Executive Officer and director of Davion Healthcare PLC (DAVI), filed a Schedule 13D reporting a significant ownership position. Mr. Kaye reported beneficial ownership of 10,268,948 ordinary shares, representing approximately 42.0% of the company's outstanding stock. This total includes 5,163,418 shares held directly by Mr. Kaye, 1,245,000 shares held through Rallinson Corp, and 3,860,530 shares held through Rallinson Ltd. As the sole director and shareholder of both Rallinson entities, Mr. Kaye maintains sole voting and dispositive power over their respective holdings. The shares were acquired using personal funds for investment purposes and to align interests as an executive. Mr. Kaye has entered into an informal voluntary lock-up agreement for 90 days following the first day of listing, after which any transactions will be subject to Rule 144 conditions. This filing marks a new reporting threshold for the CEO, establishing a major controlling interest in the issuer.